nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—SLC22A8—Furosemide—dilated cardiomyopathy	0.541	1	CbGbCtD
Saxagliptin—Hypoglycemic reaction—Lisinopril—dilated cardiomyopathy	0.0378	0.114	CcSEcCtD
Saxagliptin—DPP8—cardiac ventricle—dilated cardiomyopathy	0.0275	0.214	CbGeAlD
Saxagliptin—DPP8—myocardium—dilated cardiomyopathy	0.0258	0.201	CbGeAlD
Saxagliptin—Pancreatitis acute—Furosemide—dilated cardiomyopathy	0.0199	0.0603	CcSEcCtD
Saxagliptin—DPP9—heart—dilated cardiomyopathy	0.0198	0.154	CbGeAlD
Saxagliptin—DPP8—heart—dilated cardiomyopathy	0.018	0.141	CbGeAlD
Saxagliptin—DPP8—cardiac atrium—dilated cardiomyopathy	0.0154	0.12	CbGeAlD
Saxagliptin—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.014	0.0425	CcSEcCtD
Saxagliptin—Gastritis—Spironolactone—dilated cardiomyopathy	0.0109	0.0329	CcSEcCtD
Saxagliptin—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00977	0.0296	CcSEcCtD
Saxagliptin—DPP4—heart—dilated cardiomyopathy	0.00758	0.0591	CbGeAlD
Saxagliptin—Purpura—Furosemide—dilated cardiomyopathy	0.00693	0.021	CcSEcCtD
Saxagliptin—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00626	0.0189	CcSEcCtD
Saxagliptin—ABCC1—myocardium—dilated cardiomyopathy	0.00614	0.0479	CbGeAlD
Saxagliptin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00603	0.0182	CcSEcCtD
Saxagliptin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00591	0.0179	CcSEcCtD
Saxagliptin—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00566	0.0171	CcSEcCtD
Saxagliptin—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00565	0.0171	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00521	0.0158	CcSEcCtD
Saxagliptin—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00513	0.0155	CcSEcCtD
Saxagliptin—Face oedema—Lisinopril—dilated cardiomyopathy	0.00484	0.0146	CcSEcCtD
Saxagliptin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00479	0.0145	CcSEcCtD
Saxagliptin—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00469	0.0142	CcSEcCtD
Saxagliptin—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00448	0.0136	CcSEcCtD
Saxagliptin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00444	0.0134	CcSEcCtD
Saxagliptin—Gastritis—Lisinopril—dilated cardiomyopathy	0.00443	0.0134	CcSEcCtD
Saxagliptin—ABCC1—heart—dilated cardiomyopathy	0.00428	0.0334	CbGeAlD
Saxagliptin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00427	0.0129	CcSEcCtD
Saxagliptin—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00425	0.0128	CcSEcCtD
Saxagliptin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00417	0.0126	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00402	0.0122	CcSEcCtD
Saxagliptin—Malnutrition—Furosemide—dilated cardiomyopathy	0.00402	0.0122	CcSEcCtD
Saxagliptin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00399	0.0121	CcSEcCtD
Saxagliptin—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00399	0.0121	CcSEcCtD
Saxagliptin—Flatulence—Furosemide—dilated cardiomyopathy	0.00396	0.012	CcSEcCtD
Saxagliptin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00384	0.0116	CcSEcCtD
Saxagliptin—Rash—Spironolactone—dilated cardiomyopathy	0.0038	0.0115	CcSEcCtD
Saxagliptin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0038	0.0115	CcSEcCtD
Saxagliptin—Headache—Spironolactone—dilated cardiomyopathy	0.00378	0.0114	CcSEcCtD
Saxagliptin—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00375	0.0114	CcSEcCtD
Saxagliptin—ABCC1—cardiac atrium—dilated cardiomyopathy	0.00366	0.0286	CbGeAlD
Saxagliptin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00362	0.011	CcSEcCtD
Saxagliptin—Nausea—Spironolactone—dilated cardiomyopathy	0.00358	0.0108	CcSEcCtD
Saxagliptin—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00341	0.0103	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0034	0.0103	CcSEcCtD
Saxagliptin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00328	0.00993	CcSEcCtD
Saxagliptin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00321	0.00972	CcSEcCtD
Saxagliptin—Skin disorder—Furosemide—dilated cardiomyopathy	0.00319	0.00964	CcSEcCtD
Saxagliptin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00302	0.00913	CcSEcCtD
Saxagliptin—Flatulence—Lisinopril—dilated cardiomyopathy	0.00297	0.00899	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00283	0.00857	CcSEcCtD
Saxagliptin—Fatigue—Furosemide—dilated cardiomyopathy	0.00283	0.00856	CcSEcCtD
Saxagliptin—Angioedema—Lisinopril—dilated cardiomyopathy	0.00276	0.00834	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00268	0.00812	CcSEcCtD
Saxagliptin—Urticaria—Furosemide—dilated cardiomyopathy	0.00261	0.00789	CcSEcCtD
Saxagliptin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00259	0.00785	CcSEcCtD
Saxagliptin—Myalgia—Lisinopril—dilated cardiomyopathy	0.00257	0.00777	CcSEcCtD
Saxagliptin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00257	0.00777	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00255	0.00772	CcSEcCtD
Saxagliptin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00246	0.00745	CcSEcCtD
Saxagliptin—Infection—Lisinopril—dilated cardiomyopathy	0.00245	0.0074	CcSEcCtD
Saxagliptin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00242	0.00731	CcSEcCtD
Saxagliptin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00241	0.00729	CcSEcCtD
Saxagliptin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00239	0.00724	CcSEcCtD
Saxagliptin—Asthenia—Furosemide—dilated cardiomyopathy	0.00235	0.00712	CcSEcCtD
Saxagliptin—Pruritus—Furosemide—dilated cardiomyopathy	0.00232	0.00702	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00224	0.00679	CcSEcCtD
Saxagliptin—Dizziness—Furosemide—dilated cardiomyopathy	0.00217	0.00657	CcSEcCtD
Saxagliptin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00217	0.00656	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00213	0.00643	CcSEcCtD
Saxagliptin—Fatigue—Lisinopril—dilated cardiomyopathy	0.00212	0.00642	CcSEcCtD
Saxagliptin—Vomiting—Furosemide—dilated cardiomyopathy	0.00209	0.00631	CcSEcCtD
Saxagliptin—Rash—Furosemide—dilated cardiomyopathy	0.00207	0.00626	CcSEcCtD
Saxagliptin—Dermatitis—Furosemide—dilated cardiomyopathy	0.00207	0.00625	CcSEcCtD
Saxagliptin—Headache—Furosemide—dilated cardiomyopathy	0.00206	0.00622	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00201	0.00609	CcSEcCtD
Saxagliptin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00196	0.00592	CcSEcCtD
Saxagliptin—Nausea—Furosemide—dilated cardiomyopathy	0.00195	0.0059	CcSEcCtD
Saxagliptin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00195	0.00589	CcSEcCtD
Saxagliptin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00181	0.00549	CcSEcCtD
Saxagliptin—Asthenia—Lisinopril—dilated cardiomyopathy	0.00177	0.00534	CcSEcCtD
Saxagliptin—Pruritus—Lisinopril—dilated cardiomyopathy	0.00174	0.00527	CcSEcCtD
Saxagliptin—Dizziness—Lisinopril—dilated cardiomyopathy	0.00163	0.00493	CcSEcCtD
Saxagliptin—Vomiting—Lisinopril—dilated cardiomyopathy	0.00157	0.00474	CcSEcCtD
Saxagliptin—Rash—Lisinopril—dilated cardiomyopathy	0.00155	0.0047	CcSEcCtD
Saxagliptin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00155	0.00469	CcSEcCtD
Saxagliptin—Headache—Lisinopril—dilated cardiomyopathy	0.00154	0.00467	CcSEcCtD
Saxagliptin—Nausea—Lisinopril—dilated cardiomyopathy	0.00146	0.00442	CcSEcCtD
